Axis NIFTY Healthcare ETF
Holdings
22
Concentrated
Top 10 weight
78%
Concentration
Strategy
Index
Passive exposure
Equity
100%
Asset allocation
Portfolio
2Sectors
9Large positions
79.8%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap62%
Mid cap36%
Small cap2%
Asset allocation
Equity100%
Top holdings
18.3%
8.9%
8.0%
Cipla LimitedEQUITY
7.2%7.1%
6.5%
Laurus Labs LimitedEQUITY
6.1%6.1%
Lupin LimitedEQUITY
5.1%4.3%
Aurobindo Pharma LimitedEQUITY
3.8%2.9%
2.9%
Biocon LimitedEQUITY
2.6%2.5%
Mankind Pharma LimitedEQUITY
2.4%2.1%
Abbott India LimitedEQUITY
1.3%Piramal Pharma LimitedEQUITY
1.1%0.64%
Net Receivables / (Payables)DERIVATIVE
0.12%Clearing Corporation of India LtdDERIVATIVE
0.02%AI Smart summary
Portfolio read
- 100% equity.
- Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
- Largest equity sector is Pharmaceuticals & Biotechnology at 79.8% of the portfolio.
- Large-cap exposure is 62%.
Watchpoints
- Compact 22-position portfolio; each large position can materially affect returns.
- Top 10 positions account for 78%, indicating high portfolio concentration.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 80%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Similar index portfolios by equity allocation and concentration.
HDFC Nifty50 Value 20 ETF22 holdings · 78% top 10
Aditya Birla Sun Life NIFTY Healthcare ETF22 holdings · 78% top 10
ICICI Prudential Nifty Healthcare ETF21 holdings · 78% top 10
DSP Nifty Healthcare Index Fund22 holdings · 78% top 10
Kotak Nifty 50 Value 20 ETF21 holdings · 78% top 10
ICICI Prudential Nifty50 Value 20 ETF22 holdings · 78% top 10
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
79.8%
20.0%